NDLI: Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients

Please wait, while we are loading the content...

A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

Pre-exposure prophylaxis against rabies in children

Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: Results of In vitro and In vivo studies

Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain

Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period

Economic evaluation of Varicella vaccination: results of a systematic review

Immunization services offered in Québec (Canada) pharmacies

Particle based vaccine formulations for transcutaneous immunization

Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy

Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial

Concerns for low coverage of influenza vaccination in middle-aged adults

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles

Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents

Modern Vaccines/Adjuvants Formulation Session 6

Fourth International Conference: Modern Vaccines/Adjuvants Formulation—Impact On Future Development

Modern Vaccine Adjuvant/Formulation—Session 9: Adjuvants

Modern Vaccines/Adjuvants Formulation—Session 2 (Plenary II)

Cancer vaccines in the immunotherapy era: Rational approach

Phacilitate, Partnering for Vaccine Emerging Markets June 10–11 2013, Berlin Session

Partnering for Vaccine Emerging Markets—Berlin, June 10–11, 2013

CIMT 2013

Year: 2013, Volume: 9, Issue: 8

Year: 2013, Volume: 9, Issue: 7

Year: 2013, Volume: 9, Issue: 6

Year: 2013, Volume: 9, Issue: 5

Year: 2013, Volume: 9, Issue: 4

Year: 2013, Volume: 9, Issue: 3

Year: 2013, Volume: 9, Issue: 2

Year: 2013, Volume: 9, Issue: 1

Year: 2012, Volume: 8

Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients

Content Provider	PubMed Central
Author	Amedeo, Capetti Cossu, Maria Vittoria Laura, Carenzi Giuliano, Rizzardini
Copyright Year	2013
Abstract	We report an interventional, non-randomized experience of OM-85 BV immunization in a group of 104 HIV-infected subjects presenting recurrent seasonal respiratory bacterial infections. We compared the number of respiratory events, the use of antibiotics and the cost related to antibiotics before (2005–2006) and after (2008–2011) the introduction of such intervention. The year 2007 was excluded from the analysis since half of the patients were immunized in that year in an exploratory approach. Respiratory infections dropped in all groups but in subjects with recurrent otitis, leading to a reduction in the use of antibiotics. This is the first report of the effect of OM-85 BV in vivo in HIV-infected subjects.
Related Links	http://dx.doi.org/10.4161/hv.25104
Ending Page	1851
Page Count	3
Starting Page	1849
File Format	PDF
ISSN	21645515
e-ISSN	2164554X
Journal	Human Vaccines & Immunotherapeutics
Issue Number	9
Volume Number	9
Language	English
Publisher	Landes Bioscience
Publisher Date	2013-09-19
Access Restriction	Open
Rights Holder	Landes Bioscience
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology Pharmacology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients.

Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational Medicine

Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency ☆

Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 bindingcytokines

T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections

Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency.

The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85

Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients

Similar Documents

Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients.

Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational Medicine

Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency ☆

Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 bindingcytokines

T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections

Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency.

The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85

Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients